Pharmaceutical formulations of meloxicam
AssigneeSanovel Ilac Sanayi Ve Ticaret A.S.
InventorsHasan Ali Turp, Ali Türkyilmaz, Cevdet Akdogan
Life of this patent
Estimating the term…
Abstract
This invention is a novel pharmaceutical formulation of aqueous EDTA (Ethylene diamine tetraacetic acid) free solution of meloxicam in combination with meglumin for administration by oral or parenteral route, comprising one or more pharmaceutically acceptable excipients which is comprising N,N dimethylacetamide and propylene glycol for treating mammals, preferably animals.
Claims15
Aqueous EDTA free solution of meloxicam in combination with meglumin for administration by oral or parenteral route, comprising one or more pharmaceutically acceptable excipients, characterised in that the solution is comprising N,N dimethylacetamide and propylene glycol.
A process for the preparation of the aqueous EDTA free solution, comprising the steps:
- a. Addition of meglumin and Povidon,
- b. Addition of propylen glycol and N,N dimethylacetamid,
- c. Addition of meloxicam,
- d. Filtration
Dependencies are inferred from the claim text.